Enterprise Financial Services Corp Bluebird Bio, Inc. Transaction History

Enterprise Financial Services Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $359 - $672	-32 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $180 - $220	10 Added 45.45%	32 $1,000
Q1 2021 May 13, 2021	SELL	$16.59 - $33.89 $49 - $101	-3 Reduced 12.0%	22 $1,000
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $516 - $656	-15 Reduced 37.5%	25 $1,000
Q2 2020 Aug 04, 2020	BUY	$27.12 - $45.97 $1,084 - $1,838	40 New	40 $2,000
Q4 2018 Jan 25, 2019	SELL	$59.1 - $93.26 $827 - $1,305	-14 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$88.86 - $117.49 $1,244 - $1,644	14 New	14 $2,000
Q2 2018 Jul 27, 2018	SELL	$99.64 - $127.59 $14,946 - $19,138	-150 Closed	0 $0
Q4 2017 Jan 26, 2018	BUY	$81.25 - $130.7 $12,187 - $19,605	150	150 $27,000

142

63.2M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $605M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.